Pfizer did have the power to block other therapeut
Post# of 148175
The Drugs for Neglected Diseases initiative (DNDi) expressed concern on behalf of a consortium of 26 African and global research bodies that the drug company would not provide access to Paxlovid.1 It said that the refusal to cooperate set a “dangerous precedent” given the number of other antivirals in the pipeline and that it was difficult to understand the rationale for the decision in a global pandemic.